Compare ALEMBIC with Piramal Enterprises - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs PIRAMAL ENTERPRISES - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PIRAMAL ENTERPRISES ALEMBIC/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 59.7 -47.1 - View Chart
P/BV x 5.1 1.6 323.7% View Chart
Dividend Yield % 0.2 1.5 13.6%  

Financials

 ALEMBIC   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ALEMBIC
Mar-18
PIRAMAL ENTERPRISES
Mar-19
ALEMBIC/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs723,303 2.2%   
Low Rs341,797 1.9%   
Sales per share (Unadj.) Rs4.7716.5 0.7%  
Earnings per share (Unadj.) Rs6.179.7 7.7%  
Cash flow per share (Unadj.) Rs6.2107.9 5.8%  
Dividends per share (Unadj.) Rs0.2028.00 0.7%  
Dividend yield (eoy) %0.41.1 34.4%  
Book value per share (Unadj.) Rs40.71,477.5 2.8%  
Shares outstanding (eoy) m267.03184.45 144.8%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x11.33.6 316.5%   
Avg P/E ratio x8.732.0 27.1%  
P/CF ratio (eoy) x8.523.6 35.9%  
Price / Book Value ratio x1.31.7 75.5%  
Dividend payout %3.335.1 9.3%   
Avg Mkt Cap Rs m14,139470,292 3.0%   
No. of employees `000NA7.8 0.0%   
Total wages/salary Rs m20722,504 0.9%   
Avg. sales/employee Rs ThNM16,899.4-  
Avg. wages/employee Rs ThNM2,877.7-  
Avg. net profit/employee Rs ThNM1,879.9-  
INCOME DATA
Net Sales Rs m1,255132,153 0.9%  
Other income Rs m3703,128 11.8%   
Total revenues Rs m1,625135,281 1.2%   
Gross profit Rs m11166,290 0.2%  
Depreciation Rs m385,202 0.7%   
Interest Rs m244,097 0.0%   
Profit before tax Rs m44220,119 2.2%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m248,611 0.3%   
Profit after tax Rs m1,63014,701 11.1%  
Gross profit margin %8.950.2 17.6%  
Effective tax rate %5.442.8 12.7%   
Net profit margin %129.811.1 1,167.2%  
BALANCE SHEET DATA
Current assets Rs m1,867122,742 1.5%   
Current liabilities Rs m591310,810 0.2%   
Net working cap to sales %101.6-142.3 -71.4%  
Current ratio x3.20.4 799.7%  
Inventory Days Days9423 408.6%  
Debtors Days Days7439 189.3%  
Net fixed assets Rs m1,791116,904 1.5%   
Share capital Rs m534369 144.8%   
"Free" reserves Rs m10,324272,161 3.8%   
Net worth Rs m10,858272,530 4.0%   
Long term debt Rs m41270,196 0.0%   
Total assets Rs m11,591856,261 1.4%  
Interest coverage x260.91.5 17,914.9%   
Debt to equity ratio x01.0 0.4%  
Sales to assets ratio x0.10.2 70.2%   
Return on assets %14.16.9 205.0%  
Return on equity %15.05.4 278.3%  
Return on capital %15.212.4 122.3%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1915,200 0.1%   
Fx outflow Rs m2644,889 5.4%   
Net fx Rs m-24410,312 -2.4%   
CASH FLOW
From Operations Rs m236-115,975 -0.2%  
From Investments Rs m-224-8,265 2.7%  
From Financial Activity Rs m-27107,525 -0.0%  
Net Cashflow Rs m-15-16,650 0.1%  

Share Holding

Indian Promoters % 64.0 52.9 121.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 4.0 5.0%  
FIIs % 9.7 26.6 36.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 16.5 158.2%  
Shareholders   54,701 93,274 58.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SHASUN PHARMA  WYETH  TORRENT PHARMA  SUVEN LIFE SCIENCES  DR. REDDYS LAB  

Compare ALEMBIC With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat, GAIL and UPL Among Top Nifty Gainers(Closing)

Indian share markets continued their volatile trend during closing hours today and ended their day on a flat note.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Mar 8, 2021 03:32 PM

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS